Is GNOM options pricing rich or cheap right now?

As of Jul 15, 2026, Global X - Genomics & Biotechnology ETF (GNOM) ATM IV is 40.3% against 20-day realized volatility of 28.4%. IV rank is 17.1%. GNOM options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 11.9 vol points.

What is the GNOM variance risk premium?

The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. GNOM is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.

What does GNOM IV rank mean for strategy selection?

IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. GNOM's current rank of 17.1% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.

Global X - Genomics & Biotechnology ETF (GNOM) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Global X - Genomics & Biotechnology ETF (GNOM) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $85.9M, listed on NASDAQ, carrying a beta of 1.60 to the broader market. The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. public since 2019-04-10.

Snapshot as of Jul 15, 2026.

Spot Price: $56.12
ATM IV: 40.3%
HV 20-Day: 28.4%
HV 60-Day: 29.6%
IV Rank: 17.1%
IV Percentile: 16.7%

As of Jul 15, 2026, Global X - Genomics & Biotechnology ETF (GNOM) ATM implied volatility is 40.3%. 20-day realized volatility is 28.4%, producing an IV-HV spread of +11.9 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 17.1%.

How GNOM iv/hv history Data Feeds Strategy Selection

Strategy selection on Global X - Genomics & Biotechnology ETF options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 40.3% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the GNOM IV vs HV chart

The dual-line chart above tracks ATM implied volatility (forward-looking, what the chain is pricing) against 20-day realized historical volatility (backward-looking, what actually happened). ATM IV currently prints at 40.3%, 17.1% IV rank, against 28.4% realized over the trailing 20 trading days. Implied is pricing above realized by 11.9 vol points, the typical variance-risk-premium positive state in which premium sellers earn the gap. Persistent IV-above-HV is the variance-risk-premium-positive state typical of equity markets; persistent IV-below-HV is rare and usually marks underpriced vol that often expands.

GNOM IV/HV regimes and trade selection

GNOM sits in the bottom quartile of its 1-year IV range. Low-IV-rank regimes favor premium-buying or long-vol structures - long calls/puts, debit spreads, calendar spreads, long straddles. The risk: low rank can persist for months while theta decay eats premium-buyers alive without a vol-expansion catalyst.

Using GNOM vol history alongside the term structure

The IV/HV gap on this page captures the level of premium; the term-structure slope on the volatility page captures its shape across expirations. Backwardation (negative slope -0.053) indicates acute near-term event risk - near-dated tenors price disproportionate vol. Pair the rank read with the slope read with the event calendar to choose the right tenor for the structure.

GNOM IV/HV signal in volatility-cycle context

Equity-vol cycles tend to compress and expand on multi-month timeframes: a typical sequence runs low-IV-rank consolidation (months of flat tape, decaying premium) into a vol-expansion catalyst (earnings miss, macro shock, regime change) into elevated-IV-rank stress (premiums fat, dispersion high) back to mean-reverting compression. GNOM's current 17.1% IV rank places the ticker in the compression phase of that cycle. Compression phases are profitable for theta-harvesting structures but tend to end with abrupt vol-expansion regimes that hit short-vol books fast. The ratio of HV-20 (28.4%) to HV-60 (29.6%) gives a second cycle indicator: when 20-day exceeds 60-day, recent realization is running hotter than the trailing-quarter average - typically a sign that recent days have already started expanding vol regardless of where IV rank prints. Use the time series above to spot inflection points: meaningful IV/HV gap closures and openings tend to precede regime shifts by a few sessions.

Learn how implied vs realized volatility is reported and how to read the data →

Daily ATM implied volatility and 20-day realized (historical) volatility for GNOM over the last ~31 trading days. The IV-HV gap measures the variance risk premium - when IV trades persistently above realized HV, premium-sellers earn the spread; when IV dips below HV, vol is structurally underpriced.

Daily values from end-of-day option_ticker_snapshots. Series sparse on illiquid tickers reflects gaps in the upstream end-of-day options data feed.

Most recent 15 trading days (descending). Older history appears in the chart above.

Date	ATM IV	HV 20d	HV 60d	IV Rank
Jul 15, 2026	40.3%	28.4%	29.6%	17.1%
Jul 14, 2026	86.6%	28.6%	29.7%	56.4%
Jul 13, 2026	74.0%	28.6%	29.9%	45.7%
Jul 10, 2026	63.1%	27.2%	29.6%	36.5%
Jul 9, 2026	58.8%	21.9%	29.1%	32.8%
Jul 8, 2026	56.3%	20.3%	28.9%	30.7%
Jul 7, 2026	56.2%	18.2%	28.9%	30.6%
Jul 6, 2026	50.4%	24.9%	28.9%	25.7%
Jul 2, 2026	26.8%	26.7%	29.1%	5.7%
Jul 1, 2026	37.7%	26.6%	29.1%	14.9%
Jun 30, 2026	32.1%	27.1%	29.1%	10.2%
Jun 29, 2026	46.8%	28.3%	29.2%	22.6%
Jun 26, 2026	32.7%	27.4%	29.0%	10.7%
Jun 25, 2026	47.1%	29.4%	30.6%	22.9%
Jun 24, 2026	43.5%	29.4%	30.5%	19.8%

Frequently asked GNOM iv/hv history questions

Is GNOM options pricing rich or cheap right now?: As of Jul 15, 2026, Global X - Genomics & Biotechnology ETF (GNOM) ATM IV is 40.3% against 20-day realized volatility of 28.4%. IV rank is 17.1%. GNOM options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 11.9 vol points.
What is the GNOM variance risk premium?: The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. GNOM is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
What does GNOM IV rank mean for strategy selection?: IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. GNOM's current rank of 17.1% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.